Triple-Drug cocktail for septic shock shows promise in small trial
NCT ID NCT06155812
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether giving three blood-pressure-raising drugs (norepinephrine, angiotensin II, and vasopressin) together early in septic shock works better than the usual stepwise approach. Researchers enrolled 79 adults with severe sepsis and low blood pressure despite fluids. They measured changes in renin levels, a marker of tissue blood flow, and survival. The goal is to find a faster way to restore circulation and reduce deaths in the ICU.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
norepinephrine, angiotensin II, and vasopressin (vasopressors)
What this could lead to
If successful, this approach could lead to better blood flow and survival for patients with septic shock, potentially becoming a new standard in intensive care.
What could go wrong
This is a small, early-phase trial (79 participants) comparing two strategies, so results may not apply broadly. The drugs can cause side effects like excessive blood pressure or organ damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHOCK, SEPTIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical intensive care unit UMC Maribor
Maribor, 2000, Slovenia
-
University Hospital Centre Zagreb
Zagreb, Croatia